BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 581746)

  • 1. The possible influence of HLA-A1, B8 antigens on the course of Graves' disease.
    Balázs CS; Stenszky V; Kozma L; Leövey A
    Biomedicine; 1978 Nov; 29(8):263-4. PubMed ID: 581746
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of HLA antigens in the manifestation and course of Graves' disease.
    Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Graves' disease. Predominance of the DRw3 antigen (author's transl)].
    Allanic H; Fauchet R; Lorcy Y; Heim J; Guéguen M; Leguerrier AM; Genetet B
    Nouv Presse Med; 1980 Jun; 9(26):1823-6. PubMed ID: 6893077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K; Kordel M; Gembicki M
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connection between HLA-B8 antigen and suppressor T-cell activity in Graves' disease.
    Balázs C; Stenszky V; Kozma L; Szerze P; Leövey A
    Transplant Proc; 1979 Jun; 11(2):1314. PubMed ID: 314175
    [No Abstract]   [Full Text] [Related]  

  • 6. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
    Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
    Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
    Farid NR; Barnard JM; Marshall WH
    Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA with Graves' disease in Chinese.
    Tong ZH; Zhu G; Yan LX; Zhu J; Feng YG; Xu G
    Chin Med J (Engl); 1987 Apr; 100(4):296-8. PubMed ID: 3115694
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.
    Farid NR; Barnard JM; Marshall WH; Woolfrey I; O'Driscoll RF
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens in Asian Indian patients with Graves' disease.
    Tandon N; Mehra NK; Taneja V; Vaidya MC; Kochupillai N
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):21-6. PubMed ID: 2401095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V; Kozma L; Balazs C; Farid NR
    Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HLA DRW3 and Graves' disease (author's transl)].
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    Ann Endocrinol (Paris); 1980; 41(1):70-2. PubMed ID: 6893111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings].
    Konishi J; Grumet FC; Payne RO; Mori T; Kriss JP
    Diabete Metab; 1976 Sep; 2(3):163-4. PubMed ID: 1036991
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of HLA-antigens in Graves' disease and in autonomous adenoma of the thyroid [proceedings].
    Weise W; Wenzel KW
    Diabete Metab; 1976 Sep; 2(3):163. PubMed ID: 1036990
    [No Abstract]   [Full Text] [Related]  

  • 17. [HLA B8 and Graves' disease (author's transl)].
    Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
    Ann Endocrinol (Paris); 1976; 37(4):219-26. PubMed ID: 1037358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' ophthalmopathy, eye muscle antibodies and HLA antigens.
    Balazs C; Bokk A; Molnar I; Stenszky V; Farid NR
    Exp Clin Immunogenet; 1989; 6(2):190-2. PubMed ID: 2629892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.